Ondine Biomedical’s Chief Medical Officer, Simon Sinclair, has been interviewed for the Summer edition of European Biopharmaceutical Review about the risks of AMR and rising rates of hospital infections.

Read the full interview here: Antimicrobial resistance and healthcare-associated infections: the current landscape and the future.